Project data

The present project aims to contribute to solving a relevant issue for society, i.e. the development of safer breakthrough medical devices, by analyzing how firms’ capabilities to develop breakthrough innovations may be affected by learning by failure. The definition of more effective approaches for developing breakthrough innovations may enhance the firms’ innovativeness as well as the health outcomes achieved by national and regional health systems. The project aims to achieve two main objectives. First, a quantitative assessment of the relationships between the firm’s capability to develop breakthrough innovations and the emergence of innovation failures, with a specific focus on the two most relevant approaches that firms use to cope with uncertainty: search strategies and R&D collaborations. This will allow for defining a novel, systematic framework, enriching the existing literature by clarifying under which conditions innovation failure may favor or hamper breakthrough innovations. This novel framework is then exploited to pursue the second objective, aiming at developing a set of best practices that firms can implement to better exploit learning by failure in their future innovative efforts. These best practices result from multiple case studies in which the insights provided by the quantitative framework are further analyzed and aligned with the internal innovation processes carried out by firms operating in the medical devices industry.

 

Project website: https://breakthrough2022.santannapisa.it/

 

Disclaimer: This project is funded by European Union – NextGenerationEU – National Recovery and Resilience Plan (PNRR) – Mission 4, Component 2, Investment 1.1 Fondo per il Programma Nazionale di Ricerca e Progetti di Rilevante Interesse Nazionale (PRIN) – Project Protocol P2022C44KE – CUP J53D23015230001.